Physician profile
Gregory E Supple
NPI 1881720563
$78,407.31
in general payments reported to CMS, 2019-2025
19 companies · $28K in 2025
The $28K reported for 2025 was more than what 92% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,222 · 2020: $2,316 · 2021: $2,416 · 2022: $7,921 · 2023: $1,499 · 2024: $30K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $5,428 · Travel and Lodging: $4,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,875.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,500.00 |
| Food and Beverage | $5,427.81 |
| Travel and Lodging | $4,729.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33,871.17 | 2019-2025 | Farapulse, Versacross Access Solution, Watchman Flx |
| Medical Device Business Services, INC. | $19,001.62 | 2019-2024 | Carto 3 |
| Biosense Webster, INC. | $8,214.51 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Biotronik INC. | $5,561.59 | 2019-2022 | |
| Medtronic, INC. | $4,290.32 | 2021-2025 | Sphere-9, Pulseselect, Linq II |
| Merit Medical Systems INC | $3,300.00 | 2019-2025 | |
| Abbott Laboratories | $2,682.24 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $558.43 | 2019-2020 | |
| Zoll Respicardia, INC. | $342.98 | 2019-2024 | Remede System |
| Impulse Dynamics (USA) INC. | $181.82 | 2022-2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.43 | 2019-2025 | Lifevest |
| Adagio Medical, INC. | $81.00 | 2025 | |
| Stryker Corporation | $73.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $54.71 | 2019-2020 | |
| Abiomed | $43.11 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $19.54 | 2021 | |
| Siemens Medical Solutions USA, INC. | $19.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.63 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Supple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.